ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $80,000 | +1.3% | 12,200 | 0.0% | 0.02% | +17.6% |
| Q2 2022 | $79,000 | -30.1% | 12,200 | -50.0% | 0.02% | -22.7% |
| Q1 2022 | $113,000 | +79.4% | 24,400 | +100.0% | 0.02% | +100.0% |
| Q4 2021 | $63,000 | -49.6% | 12,200 | 0.0% | 0.01% | -52.2% |
| Q3 2021 | $125,000 | -48.3% | 12,200 | 0.0% | 0.02% | -51.1% |
| Q2 2021 | $242,000 | -28.0% | 12,200 | 0.0% | 0.05% | -33.8% |
| Q1 2021 | $336,000 | +2.4% | 12,200 | 0.0% | 0.07% | -5.3% |
| Q4 2020 | $328,000 | – | 12,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |